News
We recently published a list of 20 Takeover Rumors Hedge Funds Are Buying. In this article, we are going to take a look at ...
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
BioMarin Pharmaceutical has a 52 week low of $52.93 and a 52 week high of $94.85. The company has a debt-to-equity ratio of 0.11, a quick ratio of 2.62 and a current ratio of 5.33.
San Rafael, CA-based BioMarin Pharmaceutical Inc. focuses on the development and commercialization of treatments for life-threatening severe medical conditions, mainly for children. BMRN is a #2 ...
Below is Validea's guru fundamental report for BIOMARIN PHARMACEUTICAL INC (BMRN). Of the 22 guru strategies we follow, BMRN rates highest using our Value Investor model based on the published ...
Detailed price information for Intuitive Surg Inc (ISRG-Q) from The Globe and Mail including charting and trades.
As President Trump prepares to announce pharmaceutical tariffs, he has one country, in particular, in his sights: Ireland.
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Catalyst Pharma (CPRX – Research Report), ...
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Apellis Pharmaceuticals (APLS – Research Report), Skye ...
Learn more about whether Alvotech or Catalyst Pharmaceuticals, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
6d
Zacks Investment Research on MSNWhy BioMarin Pharmaceutical (BMRN) is a Top Growth Stock for the Long-TermIt doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results